Myelodysplastic syndromes (MDS) are a group of blood cancers in which the bone marrow does not make enough healthy blood cells.
They mainly affect people over 65 and cause tiredness, infections and bleeding because of low red cells, white cells or platelets. Some types progress slowly over years, while others can turn into acute myeloid leukaemia. Treatment ranges from monitoring and transfusions to medicines and stem cell transplant. This guide explains the signs, tests, risk groups and care.

Imagine a 74-year-old retired tailor who has felt tired and breathless for months. He bruises easily and has had two chest infections this year. A routine blood test shows low haemoglobin, low white cells and low platelets. The practice nurse notices that iron and vitamin levels are normal and refers him to a haematology clinic. A bone marrow test confirms myelodysplastic syndromes in a lower-risk group. With regular blood transfusions and a medicine that helps his marrow, he feels well enough to tend his garden again.
What is myelodysplastic syndromes?
In myelodysplastic syndromes, the stem cells in the bone marrow develop genetic changes that make them produce blood cells that are abnormal in shape and function (dysplastic) and that often die before leaving the marrow. This causes low blood counts, called cytopenias.
MDS is considered a type of cancer. It is classified by the appearance of cells under the microscope, the number of immature cells called blasts and specific genetic changes. Risk scores, such as the Revised International Prognostic Scoring System (IPSS-R and IPSS-M), help predict how the disease will behave.
MDS mainly affects people over 65 and is slightly more common in men. It may also develop after chemotherapy or radiotherapy for another cancer (therapy-related MDS).
10 key facts about myelodysplastic syndromes
- Myelodysplastic syndromes are bone marrow cancers that cause low blood counts.
- They mostly affect people over 65.
- Anaemia, causing tiredness and breathlessness, is the most common problem.
- Low white cells increase infection risk, and low platelets increase bleeding.
- Some types can progress to acute myeloid leukaemia.
- Diagnosis requires a bone marrow test.
- Risk scores guide treatment choices.
- Blood transfusions and supportive care are central for many people.
- Medicines such as luspatercept, lenalidomide and azacitidine help selected people.
- Stem cell transplant is the only potential cure.
Causes and risk factors
Most cases have no known cause. Risk factors include:
- Older age
- Previous chemotherapy or radiotherapy
- Exposure to benzene and some industrial chemicals
- Smoking
- Certain inherited bone marrow conditions
- Male sex
MDS is not contagious and is not inherited in most cases.
Symptoms and warning signs
Some people have no symptoms and are diagnosed after a routine blood test.
- Tiredness and weakness
- Breathlessness on exertion
- Pale skin
- Frequent or severe infections
- Easy bruising or bleeding
- Tiny red spots on the skin (petechiae)
- Fever
- Weight loss in some people
Fever, bleeding that will not stop, or chest pain with breathlessness need urgent care.
How myelodysplastic syndromes is diagnosed
- A full blood count shows low levels of one or more blood cell types.
- A blood film examines cell shape.
- Tests rule out other causes such as iron, vitamin B12 or folate deficiency, alcohol, medicines and infections.
- Bone marrow aspirate and biopsy confirm the diagnosis.
- Cytogenetic and molecular tests identify genetic changes.
- Risk scoring helps plan treatment.
Treatment options
- Monitoring for lower-risk myelodysplastic syndromes without major symptoms.
- Red cell transfusions for anaemia and platelet transfusions for bleeding.
- Iron chelation therapy if iron builds up from many transfusions.
- Erythropoiesis-stimulating agents to reduce transfusion needs in some people.
- Luspatercept for selected lower-risk patients.
- Lenalidomide for MDS with a specific chromosome change (del 5q).
- Hypomethylating agents such as azacitidine for higher-risk myelodysplastic syndromes.
- Allogeneic stem cell transplant for fit people with higher-risk disease.
- Supportive care, including infection prevention and palliative care.
Possible complications
- Severe anaemia
- Serious infections
- Bleeding
- Iron overload from transfusions
- Progression to acute myeloid leukaemia
Outlook
Outcomes vary widely. People with lower-risk myelodysplastic syndromes may live many years with supportive care, while higher-risk myelodysplastic syndromes progresses faster.
Treatment aims to improve quality of life, reduce transfusion needs and, in selected people, cure the disease.
Can it be prevented?
- Most MDS cannot be prevented.
- Avoid smoking and exposure to benzene.
- Use protective equipment in chemical industries.
Living with myelodysplastic syndromes
- Attend blood tests and transfusion appointments.
- Report fever immediately.
- Practise good hand hygiene.
- Use a soft toothbrush and avoid injuries if platelets are low.
- Pace activities to manage tiredness.
- Keep a list of your blood counts and treatments.
How families and communities can help
Families can help with transport to frequent appointments and support during transfusions.
Recognising infection and bleeding warning signs helps families respond quickly.
Research and new developments
Research is identifying genetic changes that drive MDS and targeted medicines.
New risk scores incorporating molecular data are improving predictions.
Around the world
MDS occurs worldwide. As populations age, more cases are diagnosed.
Access to bone marrow testing, transfusions and newer medicines varies widely.
Nursing care and the role of nurses
Haematology nurses provide much of the ongoing care.
- Recognise unexplained low blood counts.
- Give transfusions safely.
- Monitor for iron overload.
- Prevent and treat infections promptly.
- Support medicine administration.
- Provide emotional support and advance care planning.
Living with transfusions
Many people with myelodysplastic syndromes need regular red cell transfusions, sometimes every few weeks. Transfusions can quickly improve energy and breathlessness. Each visit includes checks of blood counts, pulse, blood pressure and temperature. Reactions are uncommon but can include fever, rash or breathlessness, which nurses watch for closely.
Over time, iron from transfused blood builds up in the body and can damage the heart and liver. Blood tests for ferritin monitor iron levels, and chelation medicines may be offered.
Choosing treatment with older adults
Many people with myelodysplastic syndromes are older and may have other health conditions. Treatment decisions consider not only the disease but also fitness, personal goals and preferences. Some people choose intensive treatment aiming for cure, while others prioritise comfort and quality of life. Honest conversations with the care team, family involvement and advance care planning help people make decisions that are right for them.
Palliative care teams can be involved at any stage, not only at the end of life. They help manage tiredness, breathlessness, pain and anxiety, support families and help people plan ahead, working alongside haematology teams rather than replacing them.
Infection precautions
Low white blood cells make infections more likely and more serious. Washing hands often, avoiding crowds during outbreaks, preparing food safely, keeping vaccinations up to date and seeking urgent care for fever protect people with myelodysplastic syndromes. Some people are given preventive antibiotics or antifungal medicines during treatment.
Dental care is also important, so let your dental team know about your diagnosis and blood counts before any procedure.
Keep a thermometer at home and know who to call.
Myths and facts
Myth: MDS is just anaemia.
Fact: It is a bone marrow cancer that causes anaemia and other low counts.
Myth: MDS always turns into leukaemia.
Fact: Many people, especially with lower-risk myelodysplastic syndromes, never develop leukaemia.
Myth: Older people cannot be treated.
Fact: Many treatments are suitable for older adults.
Myth: Iron tablets will fix it.
Fact: MDS anaemia is not caused by iron deficiency.
Frequently asked questions about myelodysplastic syndromes
Is MDS cancer?
Yes, it is considered a type of blood cancer.
Can MDS be cured?
Only stem cell transplant can cure it, for selected people.
How often will I need transfusions?
It varies, from rarely to every few weeks.
What is my risk group?
Your team calculates it from blood and marrow tests.
Can MDS be inherited?
Rarely.
Can younger people get MDS?
Yes, but it is uncommon.
What should I do if I get a fever?
Seek urgent care straight away.
When to seek help
- Fever or signs of infection
- Bleeding that will not stop
- Severe breathlessness or chest pain
- New bruising or tiny red spots
- Confusion or severe weakness
Key takeaways
- Myelodysplastic syndromes are bone marrow cancers that cause low blood counts.
- Low white cells increase infection risk, and low platelets increase bleeding.
- Diagnosis requires a bone marrow test.
- Risk scores guide treatment choices.
- Medicines such as luspatercept, lenalidomide and azacitidine help selected people.
- Stem cell transplant is the only potential cure.
Looking after your emotional wellbeing
Any long or worrying health problem can affect mood, sleep, relationships and confidence. Feeling anxious, low, angry or isolated after a diagnosis of myelodysplastic syndromes is common and understandable. Talking openly with family, friends, faith leaders or a support group can ease the load, and so can learning as much as you can about what to expect.
If low mood, hopelessness or worry last for more than two weeks, or if you have thoughts of harming yourself, tell your nurse or healthcare provider straight away. Emotional health is part of physical recovery, and support is available.
How to prepare for a clinic appointment
Before you see a nurse or healthcare provider, write down your symptoms, when they started and anything that makes them better or worse. Bring a list of all medicines, including herbal and traditional remedies, and any previous test results or clinic cards. If possible, bring a family member or friend to help you remember what is said.
During the appointment, ask the provider to explain anything you do not understand, and repeat the plan back in your own words. Before you leave, make sure you know what to do if symptoms get worse, when to return and who to contact with questions.
If cost, distance or work makes it hard to attend appointments, tell your nurse. Ask whether free or subsidised services, transport support, community health workers or phone follow-up are available in your area, so that practical problems do not stop you getting the care you need.
Planning ahead
Whether a health problem is short-lived or long term, a little planning makes care safer. Keep a folder or phone note with your diagnosis, medicines, allergies, recent test results and the contact details of your care team, and share it with a trusted family member. If you travel, carry enough medicines and a short letter describing your condition. Agree with your nurse or healthcare provider what to do if symptoms suddenly worsen and where to go out of hours, and review the plan whenever your treatment changes.
Support for carers
Caring for someone with a health condition can be rewarding but tiring. Carers should look after their own sleep, nutrition and health, ask relatives and friends for practical help, and ask about carer assessments, respite services and support groups in their area. Accepting help is a strength, not a failure, and it allows carers to keep supporting their loved one for longer.
Finding reliable health information
Health information online varies widely in quality. Prefer sources such as the World Health Organization, national health ministries, public health agencies, university hospitals and registered professional bodies. Be cautious with social media posts, miracle cures and products sold with promises that sound too good to be true.
If you read something that worries you or contradicts the advice you have been given, write it down and discuss it with your nurse or healthcare provider. They can explain how it applies to your own situation and help you separate evidence from rumour.
Questions to ask your nurse or healthcare provider
- What type and risk group of MDS do I have?
- What treatment options suit me?
- How often will I need transfusions?
- Is iron overload a concern?
- Am I suitable for a stem cell transplant?
- How can I reduce infection risk?
But aren’t low blood counts normal with age?
Some changes come with age, but persistent low blood counts are not normal and need investigation. A diagnosis of myelodysplastic syndromes opens the door to treatments that improve energy and quality of life.
Your next step: If routine blood tests have shown unexplained low blood counts, ask your nurse whether you need a haematology referral.
Related: Aplastic anaemia · Leukaemia · Multiple myeloma · Thalassaemia
Sources: National Cancer Institute: myelodysplastic syndromes treatment; NHS: myelodysplastic syndrome.



Leave a Reply